miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Lorraine O'Driscoll Sweta Rani Irene Ghobrial Claire Corcoran |
| Publication date | March 24, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |